ABOUT US  |  CONTACT US  |  RSS  |  ARCHIVE  |  2018-01-23  |  UPDATED: 2018/1/21 - 12:35:58 FA | AR | EN
Fatalities confirmed as Kabul hotel siege drama íendsí             Assad blasts Turkeyís support for terror groups in Syria             Brexit Fruits: More Arms sale to Saudi Arabia amid Yemen Aggression             Border Security Force: New US-designed Syria Partition Scenario             Turkish President Urges NATO Take Stance on US ĎTerrorist Armyí in Syria            Afghanistani Govt. Denies Holding Informal Talks with Taliban in Turkey             Over 22 Million Yemenis Depend on Aid Amid Saudi Aggression             Syria Pans US Plan to Set up Kurdish Border Forces as Breach of Sovereignty             Is Jordan Breaking Alliance with Saudi Arabia, West?            How Global Journalists Get Together for Freedom of Media and Peace Journalism             Over 25 Million Muslims March Against ISIS And The Mainstream Media Completely Ignores It            Texas Attack Again Marks Trump, Western Mediaís Double Standards             NATO Chief Stresses on Political Reforms in Afghanistan            Attack on TV shows Taliban, ISIS opposition to freedom of speech: Dostum             Ghani and pence discuss US strategy impact on Afghanistanian forces and Taliban            

DATE PUBLISHED: 2017/10/5 - 12:48:45
VISIT: 318
SHARE WITH YOUR FRIENDS

Europeís cancer drugs mostly ineffective: Study
 Europeís cancer drugs mostly ineffective: Study

European regulators approved 39 new cancer drugs between 2009 and 2013 despite having no evidence that they worked better than existing medicines, or at all, researchers said Thursday.

The number represented more than half of 68 treatments to become available for European cancer patients during this period, they said, "raising serious questions about the current standards of drug regulation."

Apart from dashing patient hopes, allowing unproven medicine onto the market also unnecessarily exposed people to toxicity inherent in all drugs, while inflating state pharmaceutical spending.

Writing in The BMJ medical journal, a team of public health experts expressed concern about the approval of often-pricey new cancer drugs by the EU regulator, the European Medicines Agency (EMA).

"This situation has negative implications for patients and public health," they warned.

"When expensive drugs that lack clinically meaningful benefits are approved and paid for within publicly funded healthcare systems, individual patients can be harmed, important societal resources wasted, and the delivery of equitable and affordable care undermined."

Many drugs were approved on the basis of inconclusive, early test results such as lab experiments, which were unable to predict whether they would actually make a patient feel better or live longer.

Another study, published in 2015, had found that most cancer drugs approved by the US Food and Drug Administration (FDA) between 2008 and 2012 similarly came with no evidence that they boosted patient survival or improved quality of life.

One of the authors of the American study, Vinay Prasad from the Oregon Health & Science University, pointed out that the average cancer drug in the US costs more than $100,000 (85,000 euros) per person per year.

"In the US, this broken system means huge expenditures on cancer drugs with certain toxicity but uncertain benefit," he wrote in a comment also carried by The BMJ.

"The US Medicare program is legally required to pay for any drug approved by the FDA without negotiation on price."

Given the toxicity and expense of cancer drugs, patients should be exposed only "when they can reasonably expect an improvement in survival or quality of life," said Prasad.

The new study found that 11 new drugs approved by the EMA between 2009 and 2013 were not shown to work any better than existing medicines to which they were compared, co-author Courtney Davis of Kingís College London told AFP.

In the case of 20 drugs, they worked no better than a placebo or "dummy" drug, and another eight were not compared to anything at all, "so we donít know whether they extend or improve life," she said.

 

LINK: http://ansarpress.com/english/9040






*
*

*



SEE ALSO

Uganda confirms one death from Ebola-like Marburg virus


Ghani Criticizes Services of Afghan Hospitals, Calls for Reform


Fish oil could prevent diabetes in babies, study shows


At Ramadan, group pushes positive images of Muslims


One in four young women in UK reports mental health problems: Study


Afghan minister narrowly escapes HIV infection in syringe attack by drug addict


Russian scientists find new DNA repair method to cure Alzheimerís disease: Report


Quebec court rules Canadian Tobacco firms pay smokers


Abdul Rahim says he will continue to save lives with his new hands


Iran to produce US-, Europe-licensed drugs





VIEWED
MOST DISCUSSED







POLL

Modi, Merkel Discuss Afghanistan, Radicalisation And Terrorism

SEE RESULT


LAST NEWS

US Vice President Pence arrives in Israel to discuss Trumpís al-Quds decision

Fatalities confirmed as Kabul hotel siege drama íendsí

Assad blasts Turkeyís support for terror groups in Syria

Brexit Fruits: More Arms sale to Saudi Arabia amid Yemen Aggression

Border Security Force: New US-designed Syria Partition Scenario

Turkish President Urges NATO Take Stance on US ĎTerrorist Armyí in Syria

Afghanistani Govt. Denies Holding Informal Talks with Taliban in Turkey

Over 22 Million Yemenis Depend on Aid Amid Saudi Aggression

Syria Pans US Plan to Set up Kurdish Border Forces as Breach of Sovereignty

Is Jordan Breaking Alliance with Saudi Arabia, West?

How Global Journalists Get Together for Freedom of Media and Peace Journalism

Over 25 Million Muslims March Against ISIS And The Mainstream Media Completely Ignores It

Texas Attack Again Marks Trump, Western Mediaís Double Standards

NATO Chief Stresses on Political Reforms in Afghanistan

Attack on TV shows Taliban, ISIS opposition to freedom of speech: Dostum

Ghani and pence discuss US strategy impact on Afghanistanian forces and Taliban

Iranians hold rallies to mark US embassy takeover

Mexico declares 1.5 billion barrel oil discovery

Lebanese PM Hariri resigns after trips to Saudi Arabia

Hamas Demands UKís Apology Over Balfour Declaration that Dispossessed Palestinians

US in Iraq: Taking Advantage of ISIS for Military Stay

Noor hold talks with top political figures in Kabul regarding new political coalition

Abdullah urges political circles to consider national interests in their stances

Iran, Russia, Azerbaijan to hold tripartite summit in Tehran

Mega Dream: Bin Salmanís NEOM Project Hardly Feasible

Ayatollah Khamenei urges Islamic world to continue anti-Israel fight

Whatís Behind US Striving after Syriaís Abu Kamal Seizure?

Noor prefers collapse of the government in the absence of reforms

Baltic Region in Focus as US Builds Allies Protection Belt against Russia

No bargaining with enemy on Iran defense might: Ayatollah Khamenei

Abdullah Slams Officials for Threatening Political Movements

India mulls security-related assistance to Afghanistanian forces

Death Toll In Kabul Mosque Attack Rises To Over 30

UK PM Theresa May admits Brexit negotiations with EU are in ídifficultyí

Madrid to dissolve Catalonia parliament, hold elections

Russian ships in Philippines as Manila diversifies away from US

ďNuclear Test on One Side, Discussion of Peace on the OtherĒ

MoD Accused Pakistan of Backing Taliban in Staging Recent Massive Attacks

Ghani Warns States Supporting Terrorist Networks on Isolation

Taliban Must Have No Hope Of Winning On Battlefield: CIA Chief


MEDICAL NEWS








ANSAR PRESS ©  |  ABOUT US  |  CONTACT US  |  MOBILE VERSION  |  LINKS  |  DESIGN: Negah Network Co.
All right reserved. Use this website by mentioning the source (link) is allowed. ›—ś‘ź«Ś «یš —š ی šŕŠ»šŌ«š